Ocrelizumab Treatment and Risk for Composite Disability Progression in Non-Hispanic Black and Hispanic or Latino Individuals by Self-Identity and Genetic Ancestry with Relapsing Multiple Sclerosis: Findings from the OPERA I and II Trials
MULTIPLE SCLEROSIS JOURNAL(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined